We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

194 hedge funds and large institutions have $1.62B invested in Beam Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 79 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 39

35% more call options, than puts

Call options by funds: $16.4M | Put options by funds: $12.2M

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

0.9% more ownership

Funds ownership: 84.24% → 85.14% (+0.9%)

0% more funds holding

Funds holding: 194 → 194 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $2.05B → $1.62B (-$428M)

Holders
194
Holders Change
–
Holders Change %
0%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
79
Reduced
39
Closed
30
Calls
$16.4M
Puts
$12.2M
Net Calls
+$4.21M
Net Calls Change
-$4.96M

Top Buyers

1
FCM
Farallon Capital Management
California
+$27.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$23M
3
State Street
State Street
Massachusetts
+$14.9M
4
WP
Woodline Partners
California
+$12.1M
5
NAMA
Nikko Asset Management Americas
New York
+$11.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.2M
2
Morgan Stanley
Morgan Stanley
New York
-$8.39M
3
DTC
Deep Track Capital
Connecticut
-$8.09M
4
HRCM
Hood River Capital Management
Florida
-$8.04M
5
Goldman Sachs
Goldman Sachs
New York
-$7.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
101
Trexquant Investment
Connecticut
$360K +$401K +14,952 New
VA
102
Vident Advisory
Georgia
$347K +$387K +14,446 New
ProShare Advisors
103
ProShare Advisors
Maryland
$342K +$11.2K +419 +3%
Capital Fund Management (CFM)
104
Capital Fund Management (CFM)
France
$340K +$378K +14,117 New
Osaic Holdings
105
Osaic Holdings
Arizona
$321K +$6.11K +228 +2%
Man Group
106
Man Group
United Kingdom
$315K -$1.77M -65,944 Closed
QCM
107
QRG Capital Management
Illinois
$308K +$344K +12,825 New
Zurich Cantonal Bank
108
Zurich Cantonal Bank
Switzerland
$286K +$41.5K +1,549 +15%
GCP
109
GSA Capital Partners
United Kingdom
$283K +$316K +11,785 New
Mercer Global Advisors
110
Mercer Global Advisors
Colorado
$276K +$50K +1,866 +19%
AG
111
Artal Group
Luxembourg
$264K – – –
Handelsbanken Fonder
112
Handelsbanken Fonder
Sweden
$253K – – –
PCM
113
Penserra Capital Management
California
$253K +$74.9K +2,793 +36%
Envestnet Asset Management
114
Envestnet Asset Management
Illinois
$244K -$137K -5,098 -33%
Federated Hermes
115
Federated Hermes
Pennsylvania
$241K – – –
HKAM
116
Horizon Kinetics Asset Management
New York
$241K – – –
Group One Trading
117
Group One Trading
Illinois
$238K +$216K +8,042 +433%
AB
118
Amalgamated Bank
New York
$237K – – –
Commonwealth Equity Services
119
Commonwealth Equity Services
Massachusetts
$236K +$27.6K +1,030 +12%
SEC
120
Seven Eight Capital
New York
$234K +$261K +9,747 New
VPIM
121
Vanguard Personalized Indexing Management
California
$216K +$241K +8,993 New
CIBC World Market
122
CIBC World Market
Ontario, Canada
$210K +$234K +8,721 New
Mitsubishi UFJ Asset Management
123
Mitsubishi UFJ Asset Management
Japan
$191K – – –
AIP
124
Ameritas Investment Partners
Nebraska
$163K +$30.7K +1,147 +20%
Amundi
125
Amundi
France
$160K – – –
3 4
5
6 7

BEAM Hedge Fund Activity: Q3 2023 in Review

194 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2023, worth a combined $1.62B — down 21% from $2.05B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BEAM positions and 30 closed out — a net gain of 3 holders — while 79 added to existing stakes and 39 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $27.9M. The largest seller was Fidelity Investments, cutting an estimated $17.2M.

  • 194 institutional investors held Beam Therapeutics (BEAM) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $1.62B of Beam Therapeutics stock for Q3 2023, down 21% quarter-over-quarter.
  • 33 funds opened new Beam Therapeutics positions in Q3 2023 and 30 closed out, a net change of +3 holders.
  • The largest Beam Therapeutics buyer in Q3 2023 was Farallon Capital Management, an estimated $27.9M added.
  • The largest Beam Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $17.2M sold.

Based on aggregated 13F filings for Q3 2023.